Profil
Robert Tighe is currently working as Vice President-Research at TCR2 Therapeutics, Inc. He previously worked as VP-Translational Immunology & Immunopharmacology at Compass Therapeutics, Inc.
Postes actifs de Robert Tighe
| Sociétés | Poste | Début |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Robert Tighe
| Sociétés | Poste | Fin |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
